Financial reports
10-Q
2019 Q1
Quarterly report
13 May 19
10-K/A
2018 FY
Annual report (amended)
10 Apr 19
10-K
2018 FY
Annual report
18 Mar 19
20-F/A
2017 FY
Annual report (foreign) (amended)
10 Jul 18
20-F
2017 FY
Annual report (foreign)
14 May 18
NT 20-F
Notice of late annual filing (foreign)
27 Apr 18
20-F
2016 FY
Annual report (foreign)
28 Apr 17
20-F
2015 FY
Annual report (foreign)
4 Mar 16
20-F
2014 FY
Annual report (foreign)
27 Feb 15
20-F
2013 FY
Annual report (foreign)
28 Mar 14
Current reports
8-K
Entry into a Material Definitive Agreement
1 Aug 19
8-K
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
20 Jun 19
8-K
Submission of Matters to a Vote of Security Holders
20 May 19
8-K
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
13 May 19
8-K
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results
19 Mar 19
8-K
Regulation FD Disclosure
27 Feb 19
8-K
Regulation FD Disclosure
11 Feb 19
6-K
Current report (foreign)
6 Nov 18
6-K
Arct 6-K 2018-10-15
15 Oct 18
6-K
Arcturus Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
1 Oct 18
Registration and prospectus
S-8
Registration of securities for employees
21 Jun 19
424B3
Prospectus supplement
12 Apr 19
S-4
Registration of securities issued in business combination transactions
15 Mar 19
S-8
Registration of securities for employees
15 Oct 18
424B5
Prospectus supplement for primary offering
15 Oct 18
D
$67.78M in equity, sold $67.78M, 82 investors
4 Jan 18
S-8
Registration of securities for employees
30 Nov 17
S-8
Registration of securities for employees
28 Apr 17
F-3
Shelf registration (foreign)
4 Mar 16
Proxies
No filings
Other
CT ORDER
Confidential treatment order
10 Jan 24
UPLOAD
Letter from SEC
4 Sep 19
CORRESP
Correspondence with SEC
16 Aug 19
UPLOAD
Letter from SEC
6 Aug 19
EFFECT
Notice of effectiveness
15 Apr 19
CORRESP
Correspondence with SEC
11 Apr 19
CT ORDER
Confidential treatment order
11 Apr 19
CT ORDER
Confidential treatment order
28 Nov 18
CT ORDER
Confidential treatment order
18 Oct 18
CT ORDER
Confidential treatment order
19 Jul 18
Ownership
SC 13G/A
Arcturus Therapeutics Ltd.
14 Feb 20
SC 13G/A
Arcturus Therapeutics Ltd.
20 Feb 19
SC 13G
Arcturus Therapeutics Ltd.
14 Feb 19
4
Pad Chivukula
11 Feb 19
4
Keith C Kummerfeld
11 Feb 19
4
Joseph E Payne
11 Feb 19
SC 13G/A
Arcturus Therapeutics Ltd.
25 Jan 19
3
Keith C Kummerfeld
2 Jan 19
3
Pad Chivukula
2 Jan 19
3
Joseph E Payne
2 Jan 19